ISSN: 0938-7412

Journal Home

Journal Guideline

Herzschrittmachertherapie und Elektrophysiologie Q4 Unclaimed

D. Steinkopff-Verlag Germany

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Herzschrittmachertherapie und Elektrophysiologie is a journal indexed in SJR in Medicine (miscellaneous) and Physiology (medical) with an H index of 17. It has an SJR impact factor of 0,206 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,206.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q4) Medicine (miscellaneous) (Q4) Physiology (medical) (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Herzschrittmachertherapie und Elektrophysiologie

0,206

SJR Impact factor

17

H Index

65

Total Docs (Last Year)

235

Total Docs (3 years)

1096

Total Refs

116

Total Cites (3 years)

195

Citable Docs (3 years)

0.49

Cites/Doc (2 years)

16.86

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Revista Espanola de Geriatria y Gerontologia Q4
Stomatologija Q4
Stomatologija / issued by public institution 'Odontologijos studija' ... [et al.]. Q4
Bio-Medical Materials and Engineering Q4
Current Protocols in Nucleic Acid Chemistry Q4

Compare this journals

Aims and Scope

Best articles by citations

Welche Rolle spielt die Antiarrhythmika-Therapie nach Pulmonalvenenablation?

Jede Synkope bedarf der Abklärung mit Kipptischuntersuchung: Die Contraposition

Nicht-isch'mische dilatative Kardiomyopathie: Indikation zur Defibrillator-Implantation?

Mechanisms of induction of atrial fibrillation: what do we really know?

Prevention of sudden cardiac death in heart failure: which beta blocker is best suited?

Erfahrungen mit konventionellen Schrittmachersonden aus chirurgischer Sicht

AutocaptureTM- und Capture-ManagementTM Aktuelle Konzepte zur automatischen Reizschwellenmessung und Anpassung der Stimulationsamplitude

Schrittmacher-EKG-Quiz

Secondary prevention of sudden arrhythmic death: the role of the implantable cardioverter-defibrillator

Irregularities and nonlinearities in fetal heart period time series in the course of pregnancy

Selute-Atrial-J-Trial: Eine europäische Multicenterstudie zur Performance einer neuen steroideluierenden Vorhofelektrode mit passiver Fixation

SHOW MORE ARTICLES

Elektrophysiologische Grundlagen der Hybrid-Therapie: Wie kommt es zur Konversion von Vorhofflimmern in Vorhofflattern?

Vorhofflimmern

Primary prevention of sudden cardiac death

Vorhofflimmern: Die Einleitung einer antiarrhythmischen Therapie soll ausschliebetalich stationär erfolgen (Contra)

Hochfrequenz-Katheterablation zur Therapie von Vorhofflimmern

Eine einfache Methode zur Bestimmung des AV-Intervalls bei Zweikammerschrittmachern

Hochohm-Elektroden

Rationelle ICD-Programmierung

Congress Announcements

Curative treatment of atrial fibrillation 2000: percutaneous catheter ablation techniques and intraoperative ablation with minimally invasive techniques